科研之友
微信
新浪微博
Facebook
分享链接
摘要
Objective The primary purpose of this Study was to investigate the differences in the serum brain-derived neurotrophic factor (BDNF) level between elderly Korean people over 65 years with and without dementia. Methods 171 individuals over 65 years were enrolled in this study. Screening for cognitive impairments was carried Out using the Mini-Mental Status Examination-Korean version (MMSE-KC). One hundred thirty-two Subjects scored below 1.5 standard deviations (SD) of the mean MMSE-KC score, and these were evaluated using the Consortium to Establish a Registry for Alzheimer's Disease, Korean version (CERAD-K) and the Geriatric Depression Scale (GDS), The Clinical Dementia Rating Scale (CDRS) and the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) diagnostic criteria were used for further evaluation. Subjects with a CDRS score of I or higher were classified as having Alzheimer's disease (AD), and Subjects with a CDRS score of 0.5 were classified red as having a mild cognitive impairment (MCI). Subjects with a CDRS score of 0 were classified as having aging-associated cognitive decline (AACD). Serum BDNF levels were analyzed using the enzyme-linked immunosorbent assay (ELISA) method. Results The serum BDNF levels were significantly lower in the Subjects with MCI and AD compared with the healthy controls (p<0.01). A significant correlation was found between the total MMSE-KC score and serum BDNF level (r=0.295; p<0.01). However no, significant correlation was observed between the severity of MMSE-KC and the total GDS score. A significant difference was found in the total score of GDS between the AACD group and subjects with AD (p<0.05). Conclusion This study Suggested that BDNF might be involved in the pathophysiology of cognitive decline in elderly people. Psychiatry Invest 2009;6:299-305
- 出版日期2009-12
